Metsera, Inc. — Investor Relations & Filings
Filings indexed
108
across all filing types
Latest filing
2026-02-17
Major Shareholding Noti…
Country
US
United States of America
Listing
US
MTSR
Metsera, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation medicines for obesity and related metabolic diseases. The company's portfolio includes both injectable and oral therapeutic candidates based on nutrient-stimulated hormone (NuSH) analog peptides. Leveraging a proprietary peptide engineering platform, Metsera aims to create potent, ultra-long-acting therapies with improved durability, bioavailability, and manufacturability. The company's approach is designed to deliver scalable treatments, including oral options with injectable-like performance, to enhance effectiveness, tolerability, and long-term patient adherence.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| 15-12G | 2025-11-24 | English | |
| Major Shareholding Notification 2025 | 2025-11-17 | English | |
| 4 | 2025-11-17 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English |
Browse filings by year
3 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 32333724 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
|
2025
14 filings
| |||||
| 13718408 | 15-12G | 2025-11-24 | English | ||
| 13718409 | Major Shareholding Notification 2025 | 2025-11-17 | English | ||
| 13718410 | 4 | 2025-11-17 | English | ||
| 13718411 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-14 | English | ||
| 13718412 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13718413 | Major Shareholding Notification 2025 | 2025-11-13 | English | ||
| 13718414 | 4 | 2025-11-13 | English | ||
| 13718415 | 4 | 2025-11-13 | English | ||
| 13718417 | 4 | 2025-11-13 | English | ||
| 13718416 | 4 | 2025-11-13 | English | ||
| 13718419 | 4 | 2025-11-13 | English | ||
| 13718418 | 4 | 2025-11-13 | English | ||
| 13718420 | 4 | 2025-11-13 | English | ||
| 13718421 | 4 | 2025-11-13 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ANHUI FENGYUAN PHARMACEUTICAL CO., LTD
Produces injections, solid dosage forms, APIs, and nutritio…
|
000153 | CN | Manufacturing |
|
Anhui Huangshan Capsule Co.,Ltd
Produces empty hard capsules, including gelatin and HPMC ve…
|
002817 | CN | Manufacturing |
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
Develops and manufactures pharmaceutical excipients for sol…
|
300452 | CN | Manufacturing |
|
Anika Therapeutics, Inc.
A global joint preservation company developing solutions fo…
|
ANIK | US | Manufacturing |
|
ANIMALCARE GROUP PLC
Develops and commercializes veterinary pharmaceutical produ…
|
ANCR | GB | Manufacturing |
|
ANI PHARMACEUTICALS INC
Develops, manufactures, and markets branded, generic, and O…
|
ANIP | US | Manufacturing |
|
ANLON HEALTHCARE LIMITED
Researches and manufactures APIs, intermediates, and finish…
|
AHCL | IN | Manufacturing |
|
Annexin Pharmaceuticals AB
Clinical-stage biotech developing a cell-protecting biologi…
|
ANNX | SE | Manufacturing |
|
Annexon, Inc.
Clinical-stage biopharma developing complement medicines by…
|
ANNX | US | Manufacturing |
|
Antengene Corporation Limited
Global biopharma developing and commercializing novel oncol…
|
6996 | KY | Manufacturing |
Metsera, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30975/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30975 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30975 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30975 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30975}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Metsera, Inc. (id: 30975)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.